Acadia Healthcare Company, Inc. Share Price Target ‘$88.55’, now 12.5% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Acadia Healthcare Company, Inc. which can be found using ticker (ACHC) have now 11 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $105.00 and $68.00 calculating the mean target price we have $88.55. Now with the previous closing price of $78.68 this is indicating there is a potential upside of 12.5%. The 50 day MA is $74.39 and the 200 moving average now moves to $73.44. The company has a market capitalization of 7.22B. The current share price for the company is: $78.25 USD

The potential market cap would be $8,121,143,122 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $31.58 and a 5.94% return on assets.

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. The Company is focused on acquiring and developing behavioral healthcare facilities. The Company is engaged in developing and operating inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States. Its facilities that offer acute care services provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery model that incorporates structured and intensive medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and other direct care staff. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search